117 related articles for article (PubMed ID: 1330434)
1. Rationale and design for the Asymptomatic Carotid Artery Plaque Study (ACAPS). The ACAPS Group.
Control Clin Trials; 1992 Aug; 13(4):293-314. PubMed ID: 1330434
[TBL] [Abstract][Full Text] [Related]
2. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group.
Furberg CD; Adams HP; Applegate WB; Byington RP; Espeland MA; Hartwell T; Hunninghake DB; Lefkowitz DS; Probstfield J; Riley WA
Circulation; 1994 Oct; 90(4):1679-87. PubMed ID: 7734010
[TBL] [Abstract][Full Text] [Related]
3. Effects of lovastatin and warfarin on early carotid atherosclerosis: sex-specific analyses. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group.
Byington RP; Evans GW; Espeland MA; Applegate WB; Hunninghake DB; Probstfield J; Furberg CD
Circulation; 1999 Jul; 100(3):e14-7. PubMed ID: 10411862
[TBL] [Abstract][Full Text] [Related]
4. Results of the primary outcome measure and clinical events from the Asymptomatic Carotid Artery Progression Study.
Probstfield JL; Margitic SE; Byington RP; Espeland MA; Furberg CD
Am J Cardiol; 1995 Sep; 76(9):47C-53C. PubMed ID: 7572686
[TBL] [Abstract][Full Text] [Related]
5. Estrogen replacement therapy and progression of intimal-medial thickness in the carotid arteries of postmenopausal women. ACAPS Investigators. Asymptomatic Carotid Atherosclerosis Progression Study.
Espeland MA; Applegate W; Furberg CD; Lefkowitz D; Rice L; Hunninghake D
Am J Epidemiol; 1995 Nov; 142(10):1011-9. PubMed ID: 7485045
[TBL] [Abstract][Full Text] [Related]
6. Pravastatin, lipids, and atherosclerosis in the carotid arteries: design features of a clinical trial with carotid atherosclerosis outcome.
Crouse JR; Byington RP; Bond MG; Espeland MA; Sprinkle JW; McGovern M; Furberg CD
Control Clin Trials; 1992 Dec; 13(6):495-506. PubMed ID: 1334821
[TBL] [Abstract][Full Text] [Related]
7. Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: a randomized controlled clinical trial.
Hodis HN; Mack WJ; LaBree L; Selzer RH; Liu C; Liu C; Alaupovic P; Kwong-Fu H; Azen SP
Ann Intern Med; 1996 Mar; 124(6):548-56. PubMed ID: 8597317
[TBL] [Abstract][Full Text] [Related]
8. Regression or reduction in progression of atherosclerosis, and avoidance of coronary events, with lovastatin in patients with or at high risk of cardiovascular disease: a review.
Frisinghelli A; Mafrici A
Clin Drug Investig; 2007; 27(9):591-604. PubMed ID: 17705568
[TBL] [Abstract][Full Text] [Related]
9. Reliability of longitudinal ultrasonographic measurements of carotid intimal-medial thicknesses. Asymptomatic Carotid Artery Progression Study Research Group.
Espeland MA; Craven TE; Riley WA; Corson J; Romont A; Furberg CD
Stroke; 1996 Mar; 27(3):480-5. PubMed ID: 8610317
[TBL] [Abstract][Full Text] [Related]
10. Assessment of temporal bias in longitudinal measurements of carotid intimal-medial thickness in the Asymptomatic Carotid Artery Progression Study (ACAPS). ACAPS Research Group.
Riley WA; Craven T; Romont A; Furberg CD
Ultrasound Med Biol; 1996; 22(4):405-11. PubMed ID: 8795167
[TBL] [Abstract][Full Text] [Related]
11. Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries.
Salonen R; Nyyssönen K; Porkkala E; Rummukainen J; Belder R; Park JS; Salonen JT
Circulation; 1995 Oct; 92(7):1758-64. PubMed ID: 7671358
[TBL] [Abstract][Full Text] [Related]
12. Reproducibility of noninvasive ultrasonic measurement of carotid atherosclerosis. The Asymptomatic Carotid Artery Plaque Study.
Riley WA; Barnes RW; Applegate WB; Dempsey R; Hartwell T; Davis VG; Bond MG; Furberg CD
Stroke; 1992 Aug; 23(8):1062-8. PubMed ID: 1636178
[TBL] [Abstract][Full Text] [Related]
13. Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II).
Byington RP; Furberg CD; Crouse JR; Espeland MA; Bond MG
Am J Cardiol; 1995 Sep; 76(9):54C-59C. PubMed ID: 7572688
[TBL] [Abstract][Full Text] [Related]
14. Spatial distribution of carotid intimal-medial thickness as measured by B-mode ultrasonography.
Espeland MA; Hoen H; Byington R; Howard G; Riley WA; Furberg CD
Stroke; 1994 Sep; 25(9):1812-9. PubMed ID: 8073462
[TBL] [Abstract][Full Text] [Related]
15. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts.
Post Coronary Artery Bypass Graft Trial Investigators
N Engl J Med; 1997 Jan; 336(3):153-62. PubMed ID: 8992351
[TBL] [Abstract][Full Text] [Related]
16. Intermediate-density lipoproteins and progression of carotid arterial wall intima-media thickness.
Hodis HN; Mack WJ; Dunn M; Liu C; Liu C; Selzer RH; Krauss RM
Circulation; 1997 Apr; 95(8):2022-6. PubMed ID: 9133510
[TBL] [Abstract][Full Text] [Related]
17. Modifying the natural history of atherosclerosis: the SECURE trial.
Lonn E
Int J Clin Pract Suppl; 2001 Jan; (117):13-8. PubMed ID: 11715353
[TBL] [Abstract][Full Text] [Related]
18. Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE).
Lonn E; Yusuf S; Dzavik V; Doris C; Yi Q; Smith S; Moore-Cox A; Bosch J; Riley W; Teo K;
Circulation; 2001 Feb; 103(7):919-25. PubMed ID: 11181464
[TBL] [Abstract][Full Text] [Related]
19. Comparison of ezetimibe plus simvastatin versus simvastatin monotherapy on atherosclerosis progression in familial hypercholesterolemia. Design and rationale of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression (ENHANCE) trial.
Kastelein JJ; Sager PT; de Groot E; Veltri E
Am Heart J; 2005 Feb; 149(2):234-9. PubMed ID: 15846260
[TBL] [Abstract][Full Text] [Related]
20. MIDAS: rationale, design and descriptive data of trial patients. The MIDAS Research Group.
Borhani NO
Blood Press Suppl; 1994; 1():29-35. PubMed ID: 8205295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
